Inactive Instrument
Raptor Pharmaceutical Corp Stock
Stocks
US75382F1066
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
DFI | Director of Finance/CFO | 61 | 2016-10-24 |
| Corporate Officer/Principal | 64 | 2013-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Paul Hoelscher
BRD | Director/Board Member | 61 | 2016-10-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.23% | +0.35% | +51.62% | +87.98% | 55.27B | |
| +5.09% | +6.24% | +63.15% | +62.06% | 54.15B | |
| +0.72% | -0.05% | +3.84% | +409.54% | 23.11B | |
| +0.25% | +0.55% | -19.67% | -15.22% | 23.22B | |
| +1.03% | -0.20% | +36.49% | -3.59% | 20.33B | |
| -0.37% | +0.71% | +31.36% | -31.61% | 17.91B | |
| +0.87% | -0.19% | +39.07% | +600.00% | 15.76B | |
| -2.54% | -8.73% | +164.11% | +289.45% | 15B | |
| +1.22% | -0.05% | +22.58% | +182.63% | 13.82B | |
| Average | +0.83% | +0.71% | +43.62% | +175.69% | 26.51B | |
| Weighted average by Cap. | +1.56% | +2.77% | +44.42% | +138.40% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
